Parameters | 5y-OS% | 5y-DFS% |
---|---|---|
Gender | Â | Â |
Male | 73.6 | 73.9 |
Female | 86.0 | 72.4 |
 | p=0.276 | p=0.50 |
Age | Â | Â |
≤45 years | 80.5 | 72.1 |
>45 years | 70.7 | 75.3 |
 | p=0.042 | p=0.848 |
Time interval from | Â | Â |
first radiotherapy | Â | Â |
≤2 months | 78.5 | 74.7 |
>2 months | 49.7 | 59.3 |
 | p=0.40 | p=0.925 |
T stage at diagnosis | Â | Â |
T1-2 | 83.9 | 86.2 |
T3-4 | 70.1 | 63.6 |
 | p=0.039 | p=0.039 |
N stage at diagnosis | Â | Â |
N0-1 | 80.8 | 75.2 |
N2-3 | 71.1 | 71.6 |
 | p=0.195 | p=0.805 |
Tumor volume | Â | Â |
≤10cc | 81.3 | 78.5 |
>10cc | 73.7 | 70.6 |
 | p=0.173 | p=0.260 |
BED | Â | Â |
≤30 Gy | 80.3 | 73.8 |
>30 Gy | 68.9 | 72.9 |
 | p=0.415 | p=0.968 |
Chemotherapy in primary RT | Â | Â |
no | 78.7 | 75.0 |
yes | 61.3 | 67.2 |
 | p=0.316 | p=0.317 |